单细胞转录组学揭示了缺氧驱动的iCAF_PLAU与直肠恶性黑色素瘤的干部和免疫抑制有关
Hao Zhang1,2, Lin Gan1,3, Xiaofei Duan1
1Department of Colorectal Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, Henan, China.
Journal of gastroenterology
|July 4, 2025
概括
人们对直肠恶性黑色素瘤 (ARMM) 的了解很少,但新的研究揭示了独特的纤维细胞 (iCAF_PLAU) 和巨细胞 (TAM_SPP1) 相互作用,导致瘤的攻击性和T细胞耗尽,提供了潜在的治疗点.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 基因组学就是基因组学.
背景情况:
- 异肠道恶性黑色素瘤 (ARMM) 是一种罕见且具有攻击性的癌症,对当前疗法反应不佳.
- 瘤微环境 (TME) 显著影响ARMM的进展和治疗结果.
- 了解ARMM TME特征对于开发有效的治疗策略至关重要.
研究的目的:
- 使用单细胞RNA测序,全面分析直肠恶性黑色素瘤 (ARMM) 的TME.
- 在ARMM TME中识别新的细胞群和细胞间通信网络.
- 为了发现这种耐火性恶性瘤的潜在治疗点.
主要方法:
- 在3名ARMM患者的瘤和血液样本上进行了单细胞RNA测序.
- 数据与公开可用的皮肤黑色素瘤数据集相结合,用于联合分析.
- 生物信息学分析被用来识别细胞群,突变和连接体-受体相互作用.
主要成果:
- ARMM表现出显著的内异质性,具有血管生成,缺氧,干性和上皮-介质酶过渡的特征.
- 在ARMM中发现了一种新的癌症干细胞亚群 (c5_Mel_CD55_VEPH1).
- 观察到透不良和终极耗尽的CD8+ T细胞,以及一个独特的PLAU+纤维细胞群 (iCAF_PLAU),通过WNT5A和NRG1信号增强癌症干细胞和攻击性.
- 通过iCAF_PLAU分泌的CCL2激活TAM_SPP1巨细胞,导致IL6上调和潜在的CD8+T细胞耗尽.
结论:
- 已识别的iCAF_PLAU群体在ARMM TME中的细胞相互作用中起着关键作用.
- 涉及iCAF_PLAU,TAM_SPP1和CD8+T细胞的相互作用代表了ARMM的潜在治疗点.
- 对这些途径的进一步调查可能会导致对这种侵略性癌症的新型治疗策略.
相关概念视频
Adaptive Mechanisms in Cancer Cells
5.9K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.9K
Cancer Stem Cells and Tumor Maintenance
5.0K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.0K


